Publications by authors named "Hidekazu Inoue"

Claim this Profile
B
Biliary microbiome profiling via 16 S rRNA amplicon sequencing in patients with cholangiocarcinoma, pancreatic carcinoma and choledocholithiasis.
Hiroki Mizutani, Shunsuke Fukui, Kazuki Oosuka, Kohei Ikeda, Mayu Kobayashi, Hidekazu Inoue

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characteristics of autoimmune‑like hepatitis after drug‑induced liver injury.
Kohei Ikeda, Shunsuke Fukui, Mayu Kobayashi, Yasuaki Shimada, Yuichi Nakazawa, Hidekazu Inoue

Biomed Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Soluble C-type Lectin-Like Receptor 2 Levels in Patients with Coronavirus Disease 2019-Associated with Thrombosis.
Hideo Wada, Katsuya Shiraki, Yuhuko Ichikawa, Nobuo Ito, Hidekazu Inoue

Thromb Haemost· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of a Prethrombotic State in Patients with Hepatocellular Carcinoma, Using a Clot Waveform Analysis.
Shunsuke Fukui, Hideo Wada, Kohei Ikeda, Mayu Kobayashi, Yasuaki Shimada, Hidekazu Inoue

Clin Appl Thromb Hemost· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Endoscopic Resection for Rectal Neuroendocrine Tumors Smaller than 15 mm.
Yasuhiko Hamada, Kyosuke Tanaka, Katsumi Mukai, Youichirou Baba, Makoto Kobayashi, Hidekazu Inoue

Dig Dis Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gut microbiota composition in patients with right- and left-sided colorectal cancer and after curative colectomy, as analyzed by 16S rRNA gene amplicon sequencing.
Daisuke Suga, Hiroki Mizutani, Shunsuke Fukui, Mayu Kobayashi, Yasuaki Shimada, Hidekazu Inoue

BMC Gastroenterol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal of Quick Diagnostic Criteria for Disseminated Intravascular Coagulation.
Hideo Wada, Akitaka Yamamoto, Masaki Tomida, Yuhuko Ichikawa, Minoru Ezaki, Hidekazu Inoue

J Clin Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clot Waveform Analysis Showing a Hypercoagulable State in Patients with Malignant Neoplasms.
Mayu Kobayashi, Hideo Wada, Shunsuke Fukui, Hiroki Mizutani, Yuhuko Ichikawa, Hidekazu Inoue

J Clin Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection.
Akitaka Yamamoto, Hideo Wada, Yuhuko Ichikawa, Hikaru Mizuno, Masaki Tomida, Hidekazu Inoue

J Clin Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Second basic pKa: An overlooked parameter in predicting phospholipidosis-inducing potential of diamines" [Bioorg. Med. Chem. Lett. 30 (2020) 126933].
Hiroki Sakai, Hidekazu Inoue, Kenji Murata, Tetsuya Toba, Naohiro Takemoto

Bioorg Med Chem Lett· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor receptor modulators employing diamines with reduced phospholipidosis-inducing potential.
Hiroki Sakai, Hidekazu Inoue, Kenji Murata, Tetsuya Toba, Yoshiari Shimmyo

Bioorg Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second basic pKa: An overlooked parameter in predicting phospholipidosis-inducing potential of diamines.
Hiroki Sakai, Hidekazu Inoue, Kenji Murata, Tetsuya Toba, Naohiro Takemoto

Bioorg Med Chem Lett· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Potent, Selective, and Orally Available MTHFD2 Inhibitor (DS18561882) with in Vivo Antitumor Activity.
Junya Kawai, Tadashi Toki, Masahiro Ota, Hidekazu Inoue, Yoshimi Takata

J Med Chem· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains.
Tatsunori Nakano, Hiroshi Okano, Masaharu Takahashi, Shigeo Nagashima, Katsuya Shiraki, Hidekazu Inoue

Hepatol Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 1,2,3-triazole-based fibroblast growth factor receptor modulators.
Hiroki Sakai, Hidekazu Inoue, Tetsuya Toba, Kenji Murata, Nobuhiro Narii

Bioorg Med Chem Lett· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold.
Junya Kawai, Masahiro Ota, Hitoshi Ohki, Tadashi Toki, Makoto Suzuki, Hidekazu Inoue

ACS Med Chem Lett· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of .
Naoyoshi Mori, Yuuki Nishiura, Daisuke Suga, Isao Moritani, Yutaka Yamanaka, Hidekazu Inoue

Biomed Rep· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.
Chika Kasai, Kazushi Sugimoto, Isao Moritani, Junichiro Tanaka, Yumi Oya, Hidekazu Inoue

BMC Gastroenterol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
Chika Kasai, Kazushi Sugimoto, Isao Moritani, Junichiro Tanaka, Yumi Oya, Hidekazu Inoue

Oncol Rep· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing.
Chika Kasai, Kazushi Sugimoto, Isao Moritani, Junichiro Tanaka, Yumi Oya, Hidekazu Inoue

BMC Gastroenterol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
Keiichiro Nojiri, Kazushi Sugimoto, Katsuya Shiraki, Masahiko Tameda, Yuuji Inagaki, Hidekazu Inoue

Oncol Rep· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo.
Megumi Goto, Kumiko Kadoshima-Yamaoka, Masao Murakawa, Ryosuke Yoshioka, Yoshitaka Tanaka, Hidekazu Inoue

Eur J Pharmacol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice.
Megumi Goto, Yoshitaka Tanaka, Masao Murakawa, Kumiko Kadoshima-Yamaoka, Hidekazu Inoue

Int Immunopharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphodiesterase 7A inhibitor ASB16165 suppresses proliferation and cytokine production of NKT cells.
Megumi Goto, Masao Murakawa, Kumiko Kadoshima-Yamaoka, Yoshitaka Tanaka, Hidekazu Inoue

Cell Immunol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-alpha level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice.
Kumiko Kadoshima-Yamaoka, Megumi Goto, Masao Murakawa, Ryosuke Yoshioka, Yoshitaka Tanaka, Hidekazu Inoue

Eur J Pharmacol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis